Warning against second-generation antiandrogen for metastatic castration sensitive prostate cancer.

Inoue, Takahiro; Sasaki, Takeshi; Kato, Manabu; Masui, Satoru; Nishikawa, Kohei

Inoue, Takahiro; Sasaki, Takeshi; Kato, Manabu; Masui, Satoru; Nishikawa, Kohei.

Affiliation

Inoue T; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie, Japan.
Sasaki T; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie, Japan.
Kato M; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie, Japan.
Masui S; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie, Japan.
Nishikawa K; Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Mie, Japan.

BJU Int ; 128(5): 550, 2021 11.

Article in En | MEDLINE | ID: mdl-34333840

Subject(s)

Androgen Antagonists/therapeutic use; Antineoplastic Agents/therapeutic use; Prostatic Neoplasms/drug therapy; Abiraterone Acetate/therapeutic use; Benzamides/therapeutic use; Disease Progression; Humans; Male; Nitriles/therapeutic use; Orchiectomy; Phenylthiohydantoin/therapeutic use; Prostate-Specific Antigen/blood; Prostatic Neoplasms/diagnostic imaging; Prostatic Neoplasms/pathology; Prostatic Neoplasms/surgery; Steroid Synthesis Inhibitors/therapeutic use; Thiohydantoins/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Androgen Antagonists / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Humans / Male Language: En Journal: BJU Int Journal subject: UROLOGIA Year: 2021 Type: Article Affiliation country: Japan

Fulltext

XML

PubMed Links

Search on Google